HomeEDSA • NASDAQ
Edesa Biotech Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.64M | -26.19% |
Net income | -1.59M | 14.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.61M | 25.78% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.90M | 396.37% |
Total assets | 16.45M | 154.12% |
Total liabilities | 914.70K | -57.47% |
Total equity | 15.54M | — |
Shares outstanding | 7.02M | — |
Price to book | 2.24 | — |
Return on assets | -39.74% | — |
Return on capital | -46.03% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.59M | 14.55% |
Cash from operations | -2.38M | -43.56% |
Cash from investing | — | — |
Cash from financing | 14.77M | 6,878.24% |
Net change in cash | 12.33M | 940.04% |
Free cash flow | -1.97M | -45.47% |
Previous close
$2.02
Day range
$2.01 - $2.14
Year range
$1.55 - $5.59
Market cap
14.26M USD
Avg Volume
11.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Headquarters
Website
Employees
16
